V

Vizel Cardiac Research | Cambridge, Canada

Research site
(Unclaimed)
Location
715 Coronation Boulevard, Suite 1, Cambridge, Ontario, Canada
Site insights

Top conditions

Heart Failure (3 trials)

Iron Deficiencies (1 trial)

Iron-Deficiency Anemia (1 trial)

Ischemic Stroke (1 trial)

Myocardial Infarction (1 trial)

Top treatments

Iron
Methotrexate
Finerenone
Rivaroxaban

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% (FINEARTS-HF)

The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiov...

Active, not recruiting
Heart Failure
Other: Placebo
Drug: Finerenone (BAY94-8862)

Trial sponsors

Mass General Brigham logo

Mass General Brigham (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems